Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 18, 2023

BUY
$183.43 - $232.67 $130,418 - $165,428
711 New
711 $133,000
Q4 2022

Feb 07, 2023

SELL
$187.24 - $242.74 $44,188 - $57,286
-236 Reduced 19.12%
998 $201,000
Q3 2022

Oct 25, 2022

BUY
$177.23 - $227.44 $218,701 - $280,660
1,234 New
1,234 $235,000
Q1 2022

Apr 14, 2022

BUY
$303.87 - $423.8 $1.32 Million - $1.84 Million
4,346 New
4,346 $1.52 Million
Q3 2020

Oct 27, 2020

SELL
$268.51 - $400.74 $134,255 - $200,370
-500 Closed
0 $0
Q2 2020

Jul 22, 2020

BUY
$256.46 - $373.01 $128,229 - $186,505
500 New
500 $185,000
Q1 2020

May 07, 2020

SELL
$209.2 - $335.53 $418,400 - $671,060
-2,000 Closed
0 $0
Q4 2019

Feb 06, 2020

SELL
$288.29 - $335.49 $144,145 - $167,745
-500 Reduced 20.0%
2,000 $663,000
Q3 2019

Oct 28, 2019

BUY
$266.84 - $378.23 $160,103 - $226,938
600 Added 31.58%
2,500 $760,000
Q2 2019

Aug 09, 2019

SELL
$300.59 - $368.15 $270,531 - $331,335
-900 Reduced 32.14%
1,900 $699,000
Q1 2019

May 10, 2019

SELL
$272.57 - $321.18 $8.02 Million - $9.45 Million
-29,434 Reduced 91.31%
2,800 $869,000
Q4 2018

Feb 05, 2019

BUY
$272.46 - $366.54 $281,178 - $378,269
1,032 Added 3.31%
32,234 $9.67 Million
Q3 2018

Nov 07, 2018

BUY
$279.04 - $367.06 $613,888 - $807,532
2,200 Added 7.59%
31,202 $11.5 Million
Q2 2018

Aug 10, 2018

BUY
$228.17 - $292.07 $228,170 - $292,070
1,000 Added 3.57%
29,002 $8.1 Million
Q1 2018

May 11, 2018

SELL
$209.54 - $253.91 $7.41 Million - $8.98 Million
-35,361 Reduced 55.81%
28,002 $6.62 Million
Q4 2017

Jan 17, 2018

BUY
$202.23 - $230.03 $1.98 Million - $2.25 Million
9,772 Added 18.23%
63,363 $13.8 Million
Q3 2017

Oct 17, 2017

BUY
$172.3 - $213.93 $9.23 Million - $11.5 Million
53,591
53,591 $10.7 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22.7B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.